172 related articles for article (PubMed ID: 26176765)
1. Bioorthogonal labeling cell-surface proteins expressed in pancreatic cancer cells to identify potential diagnostic/therapeutic biomarkers.
Haun RS; Quick CM; Siegel ER; Raju I; Mackintosh SG; Tackett AJ
Cancer Biol Ther; 2015; 16(10):1557-65. PubMed ID: 26176765
[TBL] [Abstract][Full Text] [Related]
2. CD109 Overexpression in Pancreatic Cancer Identified by Cell-Surface Glycoprotein Capture.
Haun RS; Fan CY; Mackintosh SG; Zhao H; Tackett AJ
J Proteomics Bioinform; 2014; Suppl 10():S10003. PubMed ID: 25635161
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the performance of secretome analysis based on metabolic labeling by three unnatural sugars].
Mao Y; Zheng J; Feng S; Tian R
Se Pu; 2021 Oct; 39(10):1086-1093. PubMed ID: 34505430
[TBL] [Abstract][Full Text] [Related]
4. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry.
Shen J; Person MD; Zhu J; Abbruzzese JL; Li D
Cancer Res; 2004 Dec; 64(24):9018-26. PubMed ID: 15604267
[TBL] [Abstract][Full Text] [Related]
5. Mass spectrometric analysis of the cell surface N-glycoproteome by combining metabolic labeling and click chemistry.
Smeekens JM; Chen W; Wu R
J Am Soc Mass Spectrom; 2015 Apr; 26(4):604-14. PubMed ID: 25425172
[TBL] [Abstract][Full Text] [Related]
6. Identification of pancreatic juice proteins as biomarkers of pancreatic cancer.
Gao J; Zhu F; Lv S; Li Z; Ling Z; Gong Y; Jie C; Ma L
Oncol Rep; 2010 Jun; 23(6):1683-92. PubMed ID: 20428826
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of pancreatic ductal adenocarcinoma compared with normal adjacent pancreatic tissue and pancreatic benign cystadenoma.
Cui Y; Tian M; Zong M; Teng M; Chen Y; Lu J; Jiang J; Liu X; Han J
Pancreatology; 2009; 9(1-2):89-98. PubMed ID: 19077459
[TBL] [Abstract][Full Text] [Related]
8. Cell surface glycoprotein profiling of cancer cells based on bioorthogonal chemistry.
Pan PW; Zhang Q; Hou J; Liu Z; Bai F; Cao MR; Sun T; Bai G
Anal Bioanal Chem; 2012 Jun; 403(6):1661-70. PubMed ID: 22526661
[TBL] [Abstract][Full Text] [Related]
9. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.
Iacobuzio-Donahue CA; Ashfaq R; Maitra A; Adsay NV; Shen-Ong GL; Berg K; Hollingsworth MA; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH
Cancer Res; 2003 Dec; 63(24):8614-22. PubMed ID: 14695172
[TBL] [Abstract][Full Text] [Related]
10. Membrane proteomic analysis of pancreatic cancer cells.
Liu X; Zhang M; Go VL; Hu S
J Biomed Sci; 2010 Sep; 17(1):74. PubMed ID: 20831833
[TBL] [Abstract][Full Text] [Related]
11. Targeted identification of metastasis-associated cell-surface sialoglycoproteins in prostate cancer.
Yang L; Nyalwidhe JO; Guo S; Drake RR; Semmes OJ
Mol Cell Proteomics; 2011 Jun; 10(6):M110.007294. PubMed ID: 21447706
[TBL] [Abstract][Full Text] [Related]
12. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.
Castillo J; Bernard V; San Lucas FA; Allenson K; Capello M; Kim DU; Gascoyne P; Mulu FC; Stephens BM; Huang J; Wang H; Momin AA; Jacamo RO; Katz M; Wolff R; Javle M; Varadhachary G; Wistuba II; Hanash S; Maitra A; Alvarez H
Ann Oncol; 2018 Jan; 29(1):223-229. PubMed ID: 29045505
[TBL] [Abstract][Full Text] [Related]
13. Targeted glycoprotein enrichment and identification in stromal cell secretomes using azido sugar metabolic labeling.
Roper SM; Zemskova M; Neely BA; Martin A; Gao P; Jones EE; Kraft AS; Drake RR
Proteomics Clin Appl; 2013 Jun; 7(5-6):367-71. PubMed ID: 23687070
[TBL] [Abstract][Full Text] [Related]
14. Metabolic labeling and click chemistry detection of glycoprotein markers of mesenchymal stem cell differentiation.
Hart C; Chase LG; Hajivandi M; Agnew B
Methods Mol Biol; 2011; 698():459-84. PubMed ID: 21431538
[TBL] [Abstract][Full Text] [Related]
15. Quantitative Proteomic Analysis of Differentially Expressed Protein Profiles Involved in Pancreatic Ductal Adenocarcinoma.
Kuo KK; Kuo CJ; Chiu CY; Liang SS; Huang CH; Chi SW; Tsai KB; Chen CY; Hsi E; Cheng KH; Chiou SH
Pancreas; 2016 Jan; 45(1):71-83. PubMed ID: 26262590
[TBL] [Abstract][Full Text] [Related]
16. Selecting targets for therapeutic validation through differential protein expression using chromatography-mass spectrometry.
Patterson S
Bioinformatics; 2002; 18 Suppl 2():S181. PubMed ID: 12386001
[TBL] [Abstract][Full Text] [Related]
17. Identification of sialylated glycoproteins from metabolically oligosaccharide engineered pancreatic cells.
Tian Y; Almaraz RT; Choi CH; Li QK; Saeui C; Li D; Shah P; Bhattacharya R; Yarema KJ; Zhang H
Clin Proteomics; 2015; 12(1):11. PubMed ID: 25987888
[TBL] [Abstract][Full Text] [Related]
18. Discovery of putative pancreatic cancer biomarkers using subcellular proteomics.
McKinney KQ; Lee YY; Choi HS; Groseclose G; Iannitti DA; Martinie JB; Russo MW; Lundgren DH; Han DK; Bonkovsky HL; Hwang SI
J Proteomics; 2011 Jan; 74(1):79-88. PubMed ID: 20807598
[TBL] [Abstract][Full Text] [Related]
19. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
[TBL] [Abstract][Full Text] [Related]
20. Novel biomarkers distinguishing pancreatic head Cancer from distal cholangiocarcinoma based on proteomic analysis.
Takenami T; Maeda S; Karasawa H; Suzuki T; Furukawa T; Morikawa T; Takadate T; Hayashi H; Nakagawa K; Motoi F; Naitoh T; Unno M
BMC Cancer; 2019 Apr; 19(1):318. PubMed ID: 30953499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
